<DOC>
	<DOCNO>NCT01093326</DOCNO>
	<brief_summary>This study extension study AC-058B201 investigate long-term safety , tolerability efficacy ponesimod patient relapsing-remitting multiple sclerosis .</brief_summary>
	<brief_title>Clinical Study Investigate Long-term Safety , Tolerability , Efficacy Ponesimod Patients With Relapsing-remitting Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<criteria>1 . Patients complete study treatment regular Week 24 ( End treatment ) visit within core study AC058B201 . 2 . Signed informed consent participate extension study . 1 . Any clinically relevant medical surgical condition , , opinion investigator , would put patient risk participate extension study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>